Sarpagandha ghanvati will be given to patients of High blood pressure

Clinical evaluation of sarpagandha ghanvati in hypertension - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055053

Enrollment

Registered

2023-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex with age between 18-70 years Patients having Systolic Blood Pressure is more than 140 and less than 180 mm of Hg Patients having Diastolic Blood Pressure is more than 90 and less than or equal to 110 mm of Hg

Exclusion criteria

Exclusion criteria: Patients of either sex below 18 years & above 70 years will be excluded from the study Patients having Systolic Blood Pressure is more than 180mm of Hg Patients having Diastolic Blood Pressure is more than 110mmHg Patients suffering from serious comorbidities like Renal failure, Coronaryartery disease, endocrinal disorder, congestive heart disease Pregnant woman

Design outcomes

Primary

Measure	Time frame
a) Headache b) Giddiness c) Palpitations d) Breathlessness e) Insomnia Timepoint: Assessment willl be done weekly for 8 weeks	—

Secondary

Measure	Time frame
1. systolic blood pressure 2. diastolic blood pressureTimepoint: Assessment of the patients will be done weekly for 8 weeks	—

Countries

India

Contacts

Public ContactManisha

Uttrakhand Ayurved University Gurukul Campus Haridwar

pandey.punita62@gmail.com9215074978

Outcome results